Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1629269

Cover Image

PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1629269

Platelet Rich Plasma Market, By Product Type, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

PUBLISHED:
PAGES: 322 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 3250
PDF (5 User License)
USD 4650
PDF & Excel (Enterprise User License)
USD 5650

Add to Cart

REPORT HIGHLIGHT

The Platelet Rich Plasma Market size was valued at USD 640.32 million in 2023, expanding at a CAGR of 15.20% from 2024 to 2032.

Platelet-rich plasma (PRP) is a biological treatment that utilizes a patient's blood to address injuries and medical conditions. The preparation of PRP involves the centrifugation of the patient's blood, which concentrates the platelets within the plasma, the fluid component of blood. This process results in a PRP formulation that has a significantly higher platelet concentration compared to standard blood, thereby facilitating an accelerated healing process. The safety of PRP therapy is assured as it employs the patient's biological material, promoting the strengthening of bodily structures rather than their deterioration. PRP therapy finds applications across various medical disciplines, including orthopedics, sports medicine, dermatology, and aesthetic treatments. It is commonly employed to manage injuries affecting muscles, tendons, ligaments, and joints, in addition to enhancing recovery in conditions such as osteoarthritis.

Platelet-Rich Plasma Market- Market Dynamics

The rising prevalence of orthopedic conditions among the aging population is expected to drive the growth of the market.

As the global demographic shifts towards an older population, the prevalence of musculoskeletal disorders, including osteoarthritis, tendonitis, ligament injuries, and joint degeneration, is on the rise. These ailments frequently result in significant pain and disability, thereby increasing the appeal of non-surgical treatment alternatives such as Platelet-Rich Plasma (PRP) therapy. The World Health Organization reports that approximately 1.71 billion individuals worldwide suffer from musculoskeletal conditions, which are the foremost contributors to disability globally. Notably, low back pain stands out as the primary cause of disability in 160 countries. Orthopedic disorders rank as the second largest source of disability on a global scale. Additionally, advancements in the technology related to PRP extraction and processing may present growth opportunities for the market. Nevertheless, the high cost associated with treatment could pose challenges to market expansion.

Platelet Rich Plasma Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 15.20% over the forecast period (2024-2032)

Based on product type segmentation, Pure Platelet Rich Plasma (Pure PRP) was predicted to show maximum market share in the year 2023

Based on application segmentation, Orthopedics was the leading segment in 2023

Based on End-User segmentation, hospitals were the leading segment in 2023

Based on region, North America was the leading revenue generator in 2023

Platelet Rich Plasma Market- Segmentation Analysis:

The Global Platelet Rich Plasma Market is segmented on the basis of Product Type, Application, End-User, and Region.

The market is divided into three categories based on product type: Pure Platelet Rich Plasma (Pure PRP), Leukocyte-rich Platelet Rich Plasma (L-PRP), Platelet Rich Fibrin (PRF), and others. Pure Platelet Rich Plasma (Pure PRP) is projected to dominate market growth. The Platelet-Rich Plasma (PRP) Market, particularly the segment focused on Pure Platelet-Rich Plasma (Pure PRP), has been growing due to its increasing application in various medical fields such as orthopedics, dermatology, and aesthetics. Pure PRP refers to a form of PRP that is free from red blood cells, white blood cells, and other blood components, containing a higher concentration of platelets that are responsible for tissue healing and regeneration. There have been significant advancements in PRP separation technologies that allow for the efficient extraction of Pure PRP. Furthermore, the leucocyte-rich segment has the potential to grow due to its increasing utility across general surgery, orthopedic, and sports injuries.

The market is categorized into two main segments based on application: Orthopedics, Sports Medicine, Cosmetic Surgery, Dermatology, Ophthalmic Surgery, Neurosurgery, General Surgery, and Others. Orthopedics is the primary driver of market expansion. The Platelet-Rich Plasma (PRP) Market within orthopedics is witnessing substantial growth due to its efficacy in addressing various musculoskeletal disorders, such as tendon injuries, ligament sprains, osteoarthritis, and muscle strains. PRP therapy is gaining traction as a non-invasive treatment that fosters healing and regeneration, serving as an alternative to conventional surgical methods. Additionally, sports medicine plays a crucial role in the PRP market, as athletes frequently encounter injuries related to their sports, including torn ligaments, muscle strains, and tendinitis. PRP is especially favored by athletes for its capacity to expedite recovery, enabling them to resume their activities more swiftly.

The market is categorized into two segments based on End-User: Hospitals, Clinics, and Others, with hospitals leading the market expansion. The Platelet-Rich Plasma (PRP) Market within hospitals is experiencing notable growth, fueled by the rising acceptance of PRP therapy as a non-surgical, minimally invasive solution for various medical issues. PRP is utilized across a wide array of therapeutic fields, such as orthopedics, dermatology, pain management, and regenerative medicine, establishing it as a vital treatment alternative in hospital environments. As hospitals increasingly incorporate PRP into their treatment frameworks, there are considerable prospects for enhancing the application of PRP in regenerative medicine and other medical specialties.

Platelet Rich Plasma Market- Geographical Insights

North America is anticipated to be a key driver of market growth, primarily attributed to the increasing adoption of Platelet Rich Plasma (PRP) within the cosmetic industry. This region serves as a center for technological advancements, with improvements in PRP preparation devices and extraction systems enhancing the effectiveness, safety, and accessibility of the procedure. Innovations in point-of-care devices facilitate faster PRP preparation in clinical settings, thereby promoting the widespread application of PRP in cosmetic treatments. The United States leads globally in the number of cosmetic procedures performed, totaling 7,347,900, which accounts for 15.5% of all surgical procedures and 30.4% of non-surgical procedures worldwide, as reported by the International Society of Aesthetic Plastic Surgery (ISAPS). Meanwhile, Europe and the Asia Pacific region are projected to witness substantial growth driven by heightened awareness, improved access to PRP therapies, and an increasing demand for non-surgical aesthetic treatments. Additionally, Latin America and the Middle East are experiencing growth, largely due to the rising popularity of PRP in cosmetic applications and the expansion of medical tourism in specific areas.

Platelet-Rich Plasma Market- Competitive Landscape:

The Platelet-Rich Plasma (PRP) Market exhibits a high level of competition, characterized by a multitude of companies that provide cutting-edge PRP-based therapies and technologies. Ongoing research and development efforts aimed at creating advanced PRP systems will enable these companies to maintain a competitive edge through product innovation, resulting in enhanced outcomes and broader acceptance. Several firms are pursuing acquisitions of smaller entities or establishing strategic partnerships to strengthen their market position, access new technologies, and diversify their product offerings. As the demand for non-invasive treatments continues to grow, especially in the fields of aesthetics and orthopedics, competition within the PRP market is expected to escalate, with both established global firms and dynamic startups playing pivotal roles in shaping its future.

Recent Developments:

Terumo Blood and Cell Technologies (Terumo BCT), a prominent entity in the field of blood management solutions, has introduced the Reveos Automated Blood Processing System in the United States. This initiative aims to assist blood centers in fulfilling their requirements for blood and platelet supplies while enhancing operational efficiency for their personnel. Carter BloodCare, located in Texas, is preparing to adopt the Reveos system for the production of platelets, red blood cells, and plasma intended for transfusion.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PLATELET RICH PLASMA MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Johnson & Johnson Services, Inc.
  • Arthrex, Inc.
  • EmCyte Corporation
  • Dr. PRP USA LLC
  • Juventix Regenerative Medical, LLC.
  • Terumo Corporation
  • Zimmer Biomet
  • Stryker
  • Apex Biologix
  • Celling Biosciences, Inc.
  • Others

GLOBAL PLATELET RICH PLASMA MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

  • Pure Platelet Rich Plasma (Pure PRP)
  • Leukocyte-rich Platelet Rich Plasma (L-PRP)
  • Platelet Rich Fibrin (PRF)
  • Others

GLOBAL PLATELET RICH PLASMA MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Orthopedics
  • Sports Medicine
  • Cosmetic Surgery
  • Dermatology
  • Ophthalmic Surgery
  • Neurosurgery
  • General Surgery
  • Others

GLOBAL PLATELET RICH PLASMA MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Others

GLOBAL PLATELET RICH PLASMA MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA
Product Code: ANV4367

Table of Contents

1. Platelet Rich Plasma Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Platelet Rich Plasma Market Snippet by Product Type
    • 2.1.2. Platelet Rich Plasma Market Snippet by Application
    • 2.1.3. Platelet Rich Plasma Market Snippet by End-User
    • 2.1.4. Platelet Rich Plasma Market Snippet by Country
    • 2.1.5. Platelet Rich Plasma Market Snippet by Region
  • 2.2. Competitive Insights

3. Platelet Rich Plasma Key Market Trends

  • 3.1. Platelet Rich Plasma Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Platelet Rich Plasma Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Platelet Rich Plasma Market Opportunities
  • 3.4. Platelet Rich Plasma Market Future Trends

4. Platelet Rich Plasma Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Platelet Rich Plasma Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Platelet Rich Plasma Market Landscape

  • 6.1. Platelet Rich Plasma Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Platelet Rich Plasma Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
    • 7.1.2. Pure Platelet Rich Plasma (Pure PRP)
    • 7.1.3. Leukocyte-rich Platelet Rich Plasma (L-PRP)
    • 7.1.4. Platelet Rich Fibrin (PRF)
    • 7.1.5. Others

8. Platelet Rich Plasma Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2. Orthopedics
    • 8.1.3. Sports Medicine
    • 8.1.4. Cosmetic Surgery
    • 8.1.5. Dermatology
    • 8.1.6. Ophthalmic Surgery
    • 8.1.7. Neurosurgery
    • 8.1.8. General Surgery
    • 8.1.9. Others

9. Platelet Rich Plasma Market - By End-User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Platelet Rich Plasma Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Platelet Rich Plasma Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Platelet Rich Plasma Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Platelet Rich Plasma Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Platelet Rich Plasma Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Platelet Rich Plasma Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Platelet Rich Plasma Industry

  • 11.1. Competitive Dashboard
    • 11.1.1. Competitive Benchmarking
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Johnson & Johnson Services, Inc.
    • 11.2.2. Arthrex, Inc.
    • 11.2.3. EmCyte Corporation
    • 11.2.4. Dr PRP USA LLC
    • 11.2.5. Juventix Regenerative Medical, LLC.
    • 11.2.6. Terumo Corporation
    • 11.2.7. Zimmer Biomet
    • 11.2.8. Stryker
    • 11.2.9. Apex Biologix
    • 11.2.10. Celling Biosciences, Inc.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!